Reports confirmed that Bard reached settlements in several thousand lawsuits previously grouped under the Bard IVC Filter MDL. These settlements were part of a broader strategy to resolve ongoing litigation linked to device failures, including filter migration and organ perforation, which were widely publicized in earlier court findings.
The US Food and Drug Administration (FDA) issued new guidelines for the use of IVC filters. The updated guidance focuses on enhanced patient monitoring and stricter criteria for implantation, to improve patient safety by recommending timely device removal and better patient selection.
A federal jury awarded $2.1 million to a plaintiff in the ongoing Cook Medical IVC filter MDL. This verdict was notable for compensating the plaintiff for severe complications attributed to a Cook IVC filter, which included device migration and subsequent organ damage.
Thousands of lawsuits against Cook Medical were still pending in a centralized federal court overseeing multiple IVC filter lawsuits (MDL) located in the Southern District of Indiana. According to some sources, more than 8,000 cases were ongoing within the Cook MDL at the time.
The Seventh Circuit Court of Appeals reversed an MDL judge's dismissal on statute of limitations grounds for two plaintiffs suing Cook Medical over IVC filters. The court ruled Cook couldn't enforce Indiana's deadline as it previously allowed plaintiffs' home state limitations within the MDL, potentially impacting other similar cases.
In a landmark decision, a Wisconsin jury awarded Natalie Johnson $3.3 million in her lawsuit against C.R. Bard. This verdict followed severe complications that Johnson experienced when her IVC filter, intended to prevent blood clots, unexpectedly migrated and punctured a vein.
In a significant victory for plaintiffs, the US Court of Appeals for the Ninth Circuit issued a favorable opinion. This federal appellate court decision, known as In re Bard IVC Filters Products Liability Litigation, established a legal precedent that could benefit future lawsuits against IVC filter manufacturers.
The IVC filter litigation primarily revolves around lawsuits filed against manufacturers of these medical devices, which are designed to prevent blood clots from reaching the lungs and causing pulmonary embolisms. These filters, typically implanted in patients who cannot take blood thinners, have come under scrutiny due to reports of serious complications.
IVC filter lawsuits have emerged as a significant area of legal action due to a variety of serious health issues experienced by patients after the implantation of these devices. The ongoing litigation has highlighted several issues with IVC filters, including:
However, the central issue of IVC filters revolves around the alleged inadequacy of warnings and misrepresentations. Lawsuits claim that manufacturers failed to provide adequate warnings about the risks associated with the filters, which, if fully disclosed, could have influenced patients and healthcare providers to consider safer alternatives.
The IVC filter litigation encompasses a range of lawsuits targeting various manufacturers. The legal actions have prominently named several key players in the medical device industry, accused of negligence and failure to ensure patient safety. However, three major manufacturers are the most frequently cited in these lawsuits.
Over the years, IVC filter litigation has culminated in numerous verdicts and settlements, which demonstrate the serious health concerns and legal issues associated with these medical devices. Some of the most notable and impactful verdicts include:
In addition to the notable verdicts, there have also been significant settlements in IVC filter lawsuits that did not proceed to a full trial, which involved undisclosed amounts to resolve claims quietly.
Working with a lawyer experienced in defective medical device claims is crucial for effectively navigating them and securing the compensation you deserve.
Get Started
The problematic IVC filters have been the subject of numerous FDA safety communications and recalls due to concerns over their potential to cause serious complications. The FDA first addressed these concerns in 2010 with a safety communication, which highlighted issues such as device migration, filter fracture, and embolization after implantation. [1]
Then, in 2014 the FDA updated its recommendations and urged physicians to remove IVC filters within 29 to 54 days after implantation if the risk of pulmonary embolism has passed. This update was based on data showing that the longer the filters remain in place, the higher the risk of complications such as filter fracture, migration, and perforation of the vena cava. [2]
As for recalls, no significant actions have been taken for almost a decade. The latest notable recall happened in March 2015, when Bard recalled 1,183 units of Denali filter due to label issues that failed to include warnings about potential complications and contraindications. [3]
Since then, there have been no new recalls or significant FDA actions related to IVC filters, leaving a gap of nearly a decade without further regulatory interventions.
The allegations surrounding IVC filters primarily focus on the claim that manufacturers failed to warn about the risks and potential complications associated with these devices. Plaintiffs argue that companies like Bard, Cook Medical, and Boston Scientific knew or should have known about the dangers but did not adequately inform patients or healthcare providers.
Inferior Vena Cava (IVC) filters were first introduced in the late 1960s as a medical device designed to prevent pulmonary embolism, a condition where blood clots travel to the lungs and can cause serious or fatal blockages.
One of the earliest successful IVC filters, the Mobin-Uddin filter, was introduced in 1967 and set the stage for further innovations in IVC filter design. In 1973, the Greenfield filter, developed by Dr. Lazar Greenfield, became one of the most widely recognized and utilized models due to its improved safety and efficacy compared to previous designs.
Over the years, the design and functionality of IVC filters have evolved significantly. By the 1980s, several new models were developed, including the Gianturco-Roehm Bird's Nest filter by Cook Medical. This model featured a unique design suitable for larger vena cava diameters and was approved in 1982.
In 1989, Boston Scientific's Greenfield filter received FDA approval, further solidifying the filter's reputation for safety and effectiveness.
The early 2000s saw further advancements, with the FDA approving IVC filters for permanent use in 2002 and for retrievable use in 2004. This development provided more flexibility in treatment options, allowing for the temporary placement of filters that could be removed once the risk of pulmonary embolism had subsided.
The use of IVC filters has been associated with a range of injuries and complications resulting from issues such as device migration, fracture, and perforation. The reliability and safety of IVC filters have been heavily researched, and multiple studies have documented and analyzed these complications.
One of the most important pieces of research is the systematic review published in the NCBI. This study emphasizes that while IVC filters are effective in preventing pulmonary embolism, they carry a significant risk of complications. It calls for improved techniques in filter design and deployment, as well as better guidelines for their use and removal. [4]
Another study published in the NCBI examined the complications associated with the use of IVC filters and highlighted that careful patient selection and regular follow-up are crucial to minimizing these risks. It also recommended retrieving the filter as soon as it is no longer needed to reduce these risks even further. [5]
In addition to these findings, ongoing research and clinical trials continue to shape the best practices for the use of IVC filters, aiming to balance their benefits with the potential risks involved.
Reach out to an experienced lawyer to find out if you qualify for an IVC filter lawsuit.
Get Started
If you or a close one has been injured or experienced complications because of a defective IVC filter, you may want to take legal action to seek justice. Filing an IVC filter lawsuit is a complex process that requires specialized legal expertise, extensive evidence gathering, and meticulous case preparation to secure a positive outcome.
If you are interested in filing an IVC filter lawsuit, the very first thing you need to do is establish whether or not you meet the eligibility criteria for pursuing this type of legal action. Generally, you may be eligible if you have experienced one of the following complications:
Furthermore, you will need to demonstrate that the manufacturer did not provide adequate warnings or instructions about the potential risks and complications associated with the IVC filter and failed to ensure the product's safety through proper testing and quality control measures.
Another important factor to consider when contemplating legal action is the time limit, also known as the statute of limitations, for filing an IVC filter lawsuit.
A statute of limitations is a legal framework that establishes the maximum time after an event within which legal proceedings may be initiated. US states have different legislations and statutes of limitations for different types of claims, including personal injury, product liability, and medical malpractice, which may all apply to an IVC filter lawsuit.
Depending on the state and jurisdiction, the statute of limitations may vary between one to six years, beginning from the date of the injury or the date when the injury was discovered, as applicable under the discovery rule.
For this reason, it is imperative that victims of IVC filter complications consult with qualified defective medical device attorneys as soon as possible to ensure that they do not miss the opportunity to file their claims within the allowable time frame. Lawyers may also identify exceptions or special circumstances that could potentially extend the usual time limits, such as cases of fraud or concealment by the manufacturer.
Damages awarded in IVC filter lawsuit settlements often depend on the type and severity of the injury caused by the IVC filter. Settlement amounts can vary significantly but typically range from $100,000 to $750,000, depending on factors like the severity of injuries, the strength of the evidence, and the defendant's conduct.
In some instances, like the notable verdicts we mentioned earlier, awards have reached into the millions to exemplify the serious repercussions for manufacturers when their products cause significant harm.
As for the types of damages that may be claimed in an IVC filter lawsuit, they can be:
Overall, each case is unique, and the potential settlement will depend on specific circumstances, including the details of the injury and the legal strategy employed.
Hiring experienced legal representatives with specialized knowledge in medical device litigation can make a world of difference in an IVC filter lawsuit. The right lawyer brings a wealth of resources and expertise that can significantly impact the outcome of a case. Here are several ways skilled product liability attorneys can assist plaintiffs in IVC filter lawsuits:
In addition to all this, a good lawyer will provide you with emotional and practical support throughout the entire legal process and help you navigate the challenges of a legal battle while dealing with physical and emotional recovery.
Overall, the right legal counsel will not only enhance the likelihood of a successful outcome for your case but also align the legal strategy with your best interests, and ensure that all aspects of the case are handled professionally and compassionately.
Several IVC filter models, including Boston Scientific's Greenfield filters, B. Braun's VenaTech filters, Cordis's OptEase filters, and Bard's Denali filters have been recalled to address issues ranging from potential organ damage to incorrect labeling instructions.
The IVC filter lawsuit involves patients suing manufacturers due to complications like device migration, fractures, and organ perforation. Many cases have been consolidated into MDL to manage numerous claims efficiently. Some lawsuits have led to significant settlements and verdicts, reflecting the serious injuries alleged.
Symptoms of IVC filter problems can include shortness of breath, chest pain, irregular heartbeat, and coughing up blood. Other signs might be redness, swelling at the surgical site, or in the legs, along with dizziness or lightheadedness. These symptoms may indicate device migration, fractures, or vein perforation.
Submit your inquiry through our contact form to start your search for legal assistance. Our directory connects you with experienced lawyers in a variety of practice areas, ensuring you have access to advice when you need it most.